News and Trends 2 Sep 2024 Are we in an AI bubble? Biotech AI startups’ value plummet and leads to restructuration Delve into the downturn AI is experiencing in biotech: Is the bubble bursting or is the market correcting the high expectations? September 2, 2024 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 30 Aug 2024The future of combination vaccines To look at combination vaccines, listen to our conversation with Cesar Sanz Rodriguez, vice president, Europe & Switzerland, medical affairs, at Moderna. August 30, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 28 Aug 2024 GLP-1 shortage: Can biotech companies keep up with rising demand? How is the biotech industry responding to the GLP-1 drug shortage? We asked experts in the field to answer this question. August 28, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 27 Aug 2024 Could microbiome drugs be the key to unlocking checkpoint inhibitors’ potential? As Microbiotica announces phase 1 approval for two microbiome drugs we delve into their potential in oncology and beyond. August 27, 2024 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 23 Aug 2024New German biotech spins out to develop radiotherapeutics While it is currently owned by the Eckert & Ziegler Group, Pentixapharm will soon be spun off as a separate company. Listen to our conversation with Andreas Eckert, founder of the company August 23, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Best in Biotech 22 Aug 2024 Seven companies transforming the biotech industry in Italy Delve into Italy’s biotech landscape with seven companies that are leading the charge in the European country. August 22, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 21 Aug 2024 The promise of antisense oligonucleotides in precision medicine Find out all about antisense oligonucleotides, which have gained a lot of popularity in recent years and could treat numerous diseases. August 21, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 20 Aug 2024 Fighting mpox: promising vaccines to watch As Bavarian Nordic ramps up production of the only marketed mpox vaccine, a few clinical trials are underway to combat the outbreak. August 20, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 16 Aug 2024Challenging the European biotech funding status quo Explore the latest trends in biotech investments and funding strategies in Europe with insights from 4BIO Capital’s Dima Kuzmin. August 16, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Best in Biotech 15 Aug 2024 10 neuroscience biotech companies you should know about Learn more about nine of the top neuroscience biotech companies looking to develop treatments for difficult-to-treat neurological conditions. August 15, 2024 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 14 Aug 2024 CAR-T drugs and parkinsonism: a cause for concern? CAR-T therapies come with boxed warnings of serious neurotoxic side effects. Now, growing concerns over parkinsonism have led to a clinical trial halt. August 14, 2024 - 3 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 13 Aug 2024 Biologics vs. drugs: What does Ipsen’s lost case against the FDA mean for the industry? Ipsen has lost a court case against U.S. regulators to have its blockbuster cancer medication Somatuline Depot regarded as a biologic instead of a drug. August 13, 2024 - 4 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email